23451-95-8

Basic information

• Product Name: 2-Amino-5-bromobenzenethiol
• Synonyms: 2-Amino-5-bromobenzenethiol;2-amino-5-bromothiophenol;2-Amino-5-bromo-benzenethiol hydrate
• CAS NO: 23451-95-8
• Molecular Formula: C₆H₆BrNS
• Molecular Weight: 204.09
• Mol File: 23451-95-8.mol
• Article Data: 37

Chemical Properties

• Melting Point: 113°C
• Boiling Point: 277°C
• Flash Point: 121°C
• Appearance: yellow solid
• Density: 1.693
• Vapor Pressure: 0.00462mmHg at 25°C
• Refractive Index: 1.695
• PKA: 7.70±0.10(Predicted)
• CAS DataBase Reference: 2-Amino-5-bromobenzenethiol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Amino-5-bromobenzenethiol(23451-95-8)
• EPA Substance Registry System: 2-Amino-5-bromobenzenethiol(23451-95-8)

Safety Data

• Hazardous Substances Data: 23451-95-8(Hazardous Substances Data)

Usage

General Description

2-Amino-5-bromobenzenethiol is a chemical compound with the molecular formula C6H6BrSH. It is also known by the alternative names 5-Bromo-2-mercaptobenzeneamine and 5-Bromo-2-thioaniline. 2-Amino-5-bromobenzenethiol is a yellow to brown solid with a slightly unpleasant odor. It is primarily used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 2-Amino-5-bromobenzenethiol is also used in the production of dyes, pigments, and other organic compounds. It is classified as a hazardous substance and should be handled with care, as it can cause irritation to the skin, eyes, and respiratory system upon exposure.

InChI:InChI=1/C6H6BrNS/c7-4-1-2-5(8)6(9)3-4/h1-3,9H,8H2

Upstream product

• 15864-32-1 2-amino-6-bromobenzothiazole 
• 5470-11-1 hydroxylamine hydrochloride 
• 20358-03-6 5‐bromo‐1,3‐benzothiazol‐2‐amine 
• 5304-21-2 6-bromo-2-methylbenzothiazole 
• 2646-30-2 1-(4-bromophenyl)thiourea 
• 63450-94-2 6-bromo-benzothiazol-2-ylamine; hydrobromide 
• 62266-82-4 6-bromo-1,3-benzothiazol-2(3H)-one 
• 106-40-1 4-bromo-aniline 
• 182499-80-5 2,2′-disulfanediylbis(4-bromoaniline) 

Downstream Products

• 60598-37-0 6-anilino-9-bromo-benzo[a]phenothiazin-5-one 
• 346691-88-1 4-(6-bromobenzo[d]thiazol-2-yl)-N,N-dimethylaniline 
• 346691-90-5 6-bromo-2-[4-(4-methyl-piperazin-1-yl)-phenyl]-benzothiazole 
• 474433-90-4 4-bromo-2-(4,5-dichloro-2-nitro-phenylsulfanyl)-phenylamine 
• 474433-92-6 4-bromo-2-(2-chloro-6-nitro-phenylsulfanyl)-phenylamine 
• 552832-63-0 methyl 2-[1-(2-amino-5-bromophenylthio)cyclopropyl]-2-chloroacetate 
• 1031747-31-5 (S)-2-(2-amino-5-bromophenylsulfanylcarbonyl)pyrrolidine-1-carboxylic acid benzyl ester 
• 938461-19-9 1-[4-(6-bromo-1,3-benzothiazol-2-yl)phenyl]-1-ethanone 
• 566169-96-8 6-bromo-2-(4-nitrophenyl)benzo[d]thiazole 

Relevant articles and documents

Synthesis and evaluation of novel benzothiazole derivatives based on the bithiophene structure as potential radiotracers for β-amyloid plaques in Alzheimer's disease

In this study, six novel benzothiazole derivatives based on the bithiophene structure were developed as potential β-amyloid probes. In vitro binding studies using Aβ aggregates showed that all of them demonstrated high binding affinities with Ki/sub

Design, synthesis and biological evaluation of benz-fused five-membered heterocyclic compounds as tubulin polymerization inhibitors with anticancer activities

A series of benz-fused five-membered heterocyclic compounds were designed and synthesized as novel tubulin inhibitors targeting the colchicine binding site. Among them, compound 4d displayed the highest antiproliferative activity against four cancer cell lines with an IC50 value of 4.9?μM in B16-F10 cells. Compound 4d effectively inhibited tubulin polymerization in vitro (IC50 of 13.1?μM). Further, 4d induced cell cycle arrest in G2/M phase. Finally, 4d inhibited the migration of cancer cells in a dose-dependent manner. In summary, these results suggest that compound 4d represents a new class of tubulin inhibitors deserving further investigation.

For the preparation and β Amyloid protein specific binding of the compound of compound, preparation method and application thereof (by machine translation)

One aspect of the invention discloses a compound, the compound has the structural formula X as shown in the structure, wherein the substituted group R1 Can be - NO2 It also can be thought that the - NHCH3 ; On the other ha